Literature DB >> 20557807

Urgent intracranial angioplasty after combined systemic and intra-arterial thrombolysis in acute stroke. An initial experience in indonesia.

Cindy Sadikin1, Agustinus Iskandar, Iswanto Pratanu, Hartono Yudi.   

Abstract

SUMMARY: We report a case of a 59-year-old man who presented with an acute stroke involving the territory of his left middle cerebral artery, and who was treated with combined systemic and intraarterial thrombolysis. After these treatments, the segment remained stenotic. An urgent intracranial angioplasty was performed, resulting in satisfactory recanalization of the stenotic segment, and significant improvement of his National Institutes of Health Stroke Scale (NIHSS) from 14 to 5. This case report suggests an effective alternate protocol for treatment of acute stroke with arterial occlusion: immediate smaller dose of IV tissue plasminogen activator (tPA), followed by angiogram, intra-arterial thrombolysis, and angioplasty if indicated.

Entities:  

Year:  2009        PMID: 20557807      PMCID: PMC3328065          DOI: 10.1177/15910199080140S216

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  8 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion.

Authors:  Takumi Yoneyama; Shinichi Nakano; Hirokazu Kawano; Tsutomu Iseda; Tokuro Ikeda; Tomokazu Goya; Shinichiro Wakisaka
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

3.  Direct percutaneous transluminal angioplasty for acute middle cerebral artery occlusion.

Authors:  S Nakano; K Yokogami; H Ohta; T Yano; T Ohnishi
Journal:  AJNR Am J Neuroradiol       Date:  1998-04       Impact factor: 3.825

4.  Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site.

Authors:  K Yokogami; S Nakano; H Ohta; T Goya; S Wakisaka
Journal:  Neurosurgery       Date:  1996-12       Impact factor: 4.654

5.  Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries.

Authors:  T Ueda; S Sakaki; I Nochide; Y Kumon; K Kohno; S Ohta
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

Review 6.  Evaluation of thrombolytic agents.

Authors:  W R Bell
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 7.  Thrombolysis in acute ischemic stroke: does it work?

Authors:  J M Wardlaw; C P Warlow
Journal:  Stroke       Date:  1992-12       Impact factor: 7.914

8.  Percutaneous transluminal angioplasty adjunct to thrombolysis for acute middle cerebral artery rethrombosis.

Authors:  F Y Tsai; B Berberian; V Matovich; M Lavin; K Alfieri
Journal:  AJNR Am J Neuroradiol       Date:  1994-11       Impact factor: 3.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.